Compare

Neuropace/$NPCE

1D1W1M3M6MYTD1Y5YMAX

About Neuropace

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Ticker
$NPCE
Sector
Health
Primary listing
NASDAQ
Employees
216

Neuropace Metrics

BasicAdvanced
$283M
-
-$0.56
1.93
-

What the Analysts think about Neuropace

Analyst ratings (Buy, Hold, Sell) for Neuropace stock.
Analyst projections of the future price of Neuropace stock.

Neuropace Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Neuropace Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise

Funds containing Neuropace

Funds
Fund name
Fund size
$NPCE weighting
Xtrackers S&P 500 Swap£XSPX
$9.1B0.02%
SPDR Russell 2000 US Small Cap€R2US
$4.7B0.01%
SPDR Russell 2000 US Small Cap£R2SC
$4.7B0.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.